Podcasts about dubilier

The Disruption Matters special podcast miniseries is back for a third season, and this year, leading industry experts discuss how private markets can best use today's technologies to create value. In the sixth and final episode of this season, we delve into how best to begin creating value using AI and other cutting-edge technology. It's no surprise that picking the right priorities is key, but so is staffing and senior management buy-in. With so many service providers, systems and apps in the market making so many promises, it's hard to imagine where to begin the process. While every GP and every portfolio company has unique needs and challenges, we offer the first principles that should guide listeners, no matter the size or strategy of the firm. Guests include Matt Katz, global head of data science at Blackstone; Chris Satchell, managing director of tech and digital at Clayton, Dubilier and Rice; Raj Kushwaha, co-head of value creation and chief digital officer at Warburg Pincus; Misha Logvinov, a managing director at MGX; Tim Kiely, operating principal at BayPine; Hoyoung Pak, global co-lead of the AI & Data Practice Group at AlixPartners; and Jason McDannold, Americas co-lead, Private Equity, at AlixPartners.

Le doliprane vendu aux américains ? C'est le scandale industriel qui a occupé les politiques la semaine dernière. Le géant pharmaceutique français Sanofi a annoncé la cession potentielle de 50% de sa filiale Opella, qui produit des médicaments grand public sans ordonnance dont le doliprane, à un fonds d'investissement américain : Clayton, Dubilier & Rice. L'entreprise s'explique : “Le projet potentiel d'indépendance d'Opella s'inscrit dans la stratégie de Sanofi de se concentrer sur les médicaments et les vaccins innovants.” Il y a quelques mois, Sanofi avait déjà supprimé 330 emplois en recherche et développement en France. Ils assuraient à ce moment là que "la France sera au cœur" de ses futurs projets de recrutements avec au moins 500 recrutements CDI d'ici 2026 et 300 créations de postes sur des métiers en tension. Le fonds français PAI a remis 200 millions sur la table, hors délais, après le scandale, et espère revenir dans la course. Avec cette vente, plusieurs centaines d'emplois français sont de nouveau menacés. Les syndicats ont lancé une grève illimitée depuis jeudi dernier. Les réactions politiques n'ont pas manqué. Le PS demande l'activation du décret Montebourg, qui permet à l'État de bloquer une vente une fois finalisée. Marc Ferracci, Ministre de l'Industrie, dit vouloir “ne pas bloquer par principe” mais demander des garanties comme le maintien de l'emploi ou de la recherche en France. Thomas Porcher critique la stratégie industrielle d'Emmanuel Macron. “Nous sommes dépendants et avons connu des pénuries de médicaments”, regrette l'économiste. Acheter les agriculteurs pour faire passer le traité de libre-échange avec le Mercosur ? Politico révèle que la commission européenne travaille sur un fonds de compensation pour les agriculteurs pour pallier les conséquences négatives de l'accord UE-Mercosur et faire plier la France qui se positionne contre. “De la viande contre des voitures, c'est non ! Message au gouvernement et à la Commission européenne : nous ne sommes ni à vendre ni à acheter !” affirme la Confédération Paysanne. Emmanuel Macron lui a réitéré son refus à Bruxelles. « Le libre échange ne fonctionne plus au 21e siècle » dépeint Thomas Porcher. Lisa Lap et Thomas Porcher décryptent tout cela, c'est l'Instant Porcher !

Nicole Dubilier, Ph.D., Director and head of the Symbiosis Department at the Max Planck Institute for Marine Microbiology, has led numerous reserach cruises and expeditions around the world studying the symbiotic relationships of bacteria and marine invertebrates. She discusses how the use of various methods, including deep-sea in situ tools, molecular, 'omic' and imaging analyses, have illuminated remarkable geographic, species and habitat diversity amongst symbionts and emphasizes the importance of discovery-driven research over hypothesis-driven methods. Watch this episode: https://www.youtube.com/watch?v=OC9vqE1visc Ashley's Biggest Takeaways: In 1878, German surgeon, botanist and microbiologist, Heinrich Anton de Bary, first described symbiosis as the living together of two or more different organisms in close physical intimacy for a longer period of time.  These relationships can be beneficial, detrimental or commensal, depending on the organisms involved.  Microbial symbiosis research holds great potential to contribute to sustainable energy production and environmental health. Links for This Episode: Learn more about one of Dubilier's research vessels and see videos from the expidition. Functional diversity enables multiple symbiont strains to coexist in deep-sea mussels. Chemosynthetic symbioses: Primer. Take the MTM listener survey!

Planful announced record-breaking new bookings for the first half of the year 2024. Clayton, Dubilier, & Rice and CVC today announced that funds managed by CVC have agreed to acquire a significant ownership position in Epicor. Sage announced new enhancements and updates for Sage Intacct customers globally, to streamline financial operations and enhance security. Certinia accounted its Summer 2024 Release, introducing enhanced features to help customers achieve enterprise-level scalability, drive new efficiencies across their professional services and customer success organizations, and unlock tangible benefits with AI. Oracle introduced new user experience enhancements to Oracle Fusion Cloud Supply Chain & Manufacturing (SCM). Salesforce launched Pulse for Salesforce, a purpose-built edition of Tableau Pulse that brings out-of-the-box metrics and AI-powered insights directly into the flow of work in Salesforce CRM, starting with Sales Cloud.Connect with us!https://www.erpadvisorsgroup.com866-499-8550LinkedIn:https://www.linkedin.com/company/erp-advisors-groupTwitter:https://twitter.com/erpadvisorsgrpFacebook:https://www.facebook.com/erpadvisorsInstagram:https://www.instagram.com/erpadvisorsgroupPinterest:https://www.pinterest.com/erpadvisorsgroupMedium:https://medium.com/@erpadvisorsgroup

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Pfizer is terminating its Duchenne gene therapy program, resulting in the layoff of 150 staff members. Boehringer has acquired startup Nerio for up to $1.3 billion to expand its cancer drug pipeline. Emerging biotech IPOs are showing signs of life after a slow period. GSK has cut vaccine forecasts due to slowing sales of its shingles vaccine. Stakeholders in clinical research are exploring the use of real-world evidence for external control arms. Stryker CEO Kevin Lobo plans to be "very active" in mergers and acquisitions after another successful quarter of orthopedic robot installations. Guardant Health has received FDA approval for a blood test for colon cancer, which could increase screening rates. The FDA approved Tecelra, an engineered T cell therapy, as a breakthrough for solid tumors by Adaptimmune Therapeutics. CMS finalized higher hospital payments for 2025, with a 2.9% increase in inpatient payment rates.Humana expects to lose a few hundred thousand Medicare Advantage members next year due to a reduction in its plan footprint for 2025. Optum is laying off more than 500 workers in California, affecting urgent care locations, clinics, and office workers. A data breach at HealthEquity could impact 4.3 million individuals. The FDA has approved Tecelra, an engineered T cell therapy, as a breakthrough for solid tumors. Revenue cycle management firm R1 RCM is set to go private in an $8.9 billion acquisition deal with private equity firms TowerBrook and Clayton, Dubilier and Rice.Despite concerns about data security and privacy challenges, AI is being used in areas such as science and clinical trials to gain insights, predict patient outcomes, and enhance efficiency within the pharma industry. Pharma is learning from AI tools, moving from hype to a daily reality, with insights being gained on what makes trials successful and how AI can improve various processes within pharma companies.Support the Show.

Han har ledet både Equinor og Aker, her gir han verdifulle råd til andre som ønsker å bli en god leder, en god medarbeider, bli lyttet til, og få tillit i selskapet og bransjen. Helge Lund begynte sin karriere som rådgiver for Høyre og som konsulent i McKinsey, nå er han styreleder for BP og Novo Nordisk og jobber for investeringsselskapet Clayton, Dubilier & Rice i London. Hosted on Acast. See acast.com/privacy for more information.

Seattle: The background story. William Dubilier: The forgotten radio inventor. Our first report from the HFCC B22 conference in Sofia Bulgaria. Philippine DX report from Henry Umadhay.

Seattle: The background story. William Dubilier: The forgotten radio inventor. Our first report from the HFCC B22 conference in Sofia Bulgaria. Philippine DX report from Henry Umadhay.

Thomas Franco is a veteran of the private equity industry and currently leads fundraising at Clayton, Dubilier, & Rice (CD&R), one of the largest and oldest private equity firms in the world. Tom provides incredible insight on his journey into the private equity world, the rise of CD&R in the early days of the industry, and lessons learned from leading fundraising for over 15 years. We also discuss CD&R's investment strategy and focus on operational value-add, alongside the rise of specialization within the private equity space. We conclude with a conversation on the role his liberal arts education had on his successful career and advice for those interested in finance.

Morrisons board has now switched its recommendation to shareholders to back the improved offer from Clayton, Dubilier and Rice valuing grocer at just over £7 billion pounds.

FoodBev Media's Rafaela Sousa rounds up this week's food and beverage news, including Clayton, Dubilier & Rice strikes £7bn deal to buy Morrisons; PepsiCo pledges to be “net water positive” by 2030; Coca-Cola HBC to buy majority stake in Coca-Cola Bottling Company of Egypt for $427m; and more.

The topics, stocks and shares mentioned/discussed include: One of Peter @conkers3' research & investment strategies One of Pete @wheeliedealer' research & investment strategies Watchlists Fundamental Analysis Technical Analysis Recovery plays Spotting a catalyst Position sizing Investment methodology Intrinsic Value Sum of the Parts SOTP Paypal $PYPL Morrisons MRW Tesco Sir Terry Leahy Clayton, Dubilier & Rice CDR Amazon $AMZN Aviva AV. Kin+Carta KCT GlaxoSmithKline GSK London Stock Exchange LSEG AstraZeneca AZN Refinitiv Takeovers Private Equity Online Shopping Online Retail Artificial Intelligence AI BigData Fintech Pharma Machine Learning  ML Book: Security Analysis, by Benjamin Graham & David L. Dodd Book: The Intelligent Investor, by  Benjamin Graham England Football Team / EURO 2020 Market Volatility Spreadbetting Talk Talk Digital Native CMO Group IPO Bridgepoint IPO Revolution Beauty IPO Learning Objectivity FTSE AIM The Twin Petes Challenge / Charity fundraise for the Menphys Charity Trading & More WE HOPE YOU ENJOYED THIS PODCAST. IF YOU DID PLEASE SHARE IT ACROSS SOCIAL MEDIA & WITH FRIENDS/ASSOCIATES YOU KNOW THAT HAVE AN INTEREST IN INVESTING OR TRADING STOCKS / SHARES. PLEASE SUBSCRIBE FOR FREE TO THIS PODCAST.

The Bid For Morrison’s Supermarket Join Andrew Grant and Darren A. Smith in the thirty-third episode of the Grocery Guru. They discuss the bid from United States private equity firm Clayton, Dubilier & Rice, of which Terry Leahy is a Board Member, to buy Morrison’s Supermarkets. But will Amazon now make a bid too? Join Darren and Andrew as they discuss the bid for Morrison’s supermarket You Can View the Full Bid For Morrison’s Supermarket Transcript Below Darren A. Smith: Welcome to episode 33 of the Grocery Guru. And we are here today with that guru, Andrew Grant. How are you? Andrew Grant: Yeah, morning Darren. Yes, very good. Thank you very much. Darren A. Smith: Now, we’ve both had the lurgy, but that’s not why we’re on video, to tell everyone we’ve had the lurgy. Andrew Grant: No, I think you’re right. As I think you put it, we’ve done so little social interaction in the last 15 months. At the minute, you actually come near anybody else, you catch something. Darren A. Smith: Does seem that way, does seem that way. But more interestingly, for our viewers out there, what’s in our postbox, mail bag, on your lips, on your mind today? Andrew Grant: Well, there’s only one big news in the world of grocery today, I’m sure nobody’s missed it. But it’s the possible bid for Morrisons. Interestingly, we’re doing this a couple of days late. It’s Monday morning. The news broke Friday, that… What are they called? Clayton Dubilier & Rice? American venture capital group. Best known for floating B&M, Home Bargains. Darren A. Smith: Oh! I didn’t know that. Okay. Andrew Grant: And have got ex Tesco CEO Terry Leahy on their board. So, they’ve got a bit of knowledge and a bit of experience. But yeah, that news broke Friday evening. And this morning, Morrisons’ shares have gone up over 30%. Darren A. Smith: So, the news is that this venture capitalist, what do they want to do? I know you know this. Andrew Grant: Well, interestingly the supermarkets are incredibly good value. We’ve talked so many times in these sessions of how well we did over the pandemic, et cetera. But that hasn’t been reflected in their share prices. Darren A. Smith: No. Andrew Grant: And there was an article I read yesterday, to say that Morrisons’ share price prior to today, was the same as it was 20 years ago. Darren A. Smith: Wow! Okay. Andrew Grant: So, all that effort, hard work by 115,000 people wh

In the first episode of the new series, Ludovic Phalippou and Vindi Banga discuss the sometimes controversial world of private equity. Ludo and Vindi explore how many private equity-backed companies weathered the Covid-19 crisis well, and address some of the controversial issues associated with the sector – typically high levels of debt have led to the collapse of some potentially viable companies, while many PE-controlled companies had to be ‘rescued’ by the tax-payer. Featuring: Ludovic Phalippou (@lphalippou81), Professor of Financial Economics, Saïd Business School, University of Oxford. Vindi Banga, partner, Clayton, Dubilier & Rice. Peter Tufano, Peter Moores Dean and Professor of Finance at Saïd Business School, University of Oxford. Resources: Private Equity Laid Bare (book) Private Equity Laid Bare (podcast) https://www.sbs.ox.ac.uk/ Producer/editor – Eve Streeter for Stabl

Paul Bird, a partner at Debevoise & Plimpton, discusses his work for Clayton, Dubilier & Rice and Aveva's acquisition of OSIsoft on the latest episode of Drinks With The Deal.

With over 20 years of executive and financial leadership experience, Mike has operated, advised and invested in companies across a broad range of industries and stages from startups to mature enterprises. Prior to co-founding Jump Capital, he was a senior partner for Excelar Group LLC, a provider of strategic execution and advisory services. He also served as President of SIRVA, a Clayton, Dubilier & Rice portfolio company. Mike spent sixteen years with GE and GE Capital in a breadth of financial, operating and global assignments and is an honors graduate from GE's Financial Management and Leadership Development programs.

Trevor and Steve chat with Ravi Sachdev, Partner at Clayton, Dubilier & Rice.

If you thought the battle between machines and jobs – the dislocation of labor and society resulting from digitization or automation – has been one-sided so far, just wait. The next wave of attack is well underway, and it’s called AI. Artificial Intelligence, most simply, refers to computers that perform tasks that normally require human intelligence – things like visual perception, speech recognition, even decision-making.Earlier this year the management consulting firm McKinsey famously wrote that “25 percent of the global workforce will either need to find new professional activities by 2020 or significantly broaden their technological skills. The World Economic Forum’s “Future of Jobs Report: 2018” states, “By 2022, the skills required to perform most jobs will have shifted significantly… [and] no less than 54% of all employees will require significant re- and upskilling.”The greatest concerns are not just that AI destroys jobs, but that it increases inequality – that low-wage employees get displaced, while high-wage employees maintain or even extend their value that’s more difficult to replace with a machine.Of course, new technologies have disrupted existing processes for centuries. Steam engines. Electricity. Microprocessors. Will the experience with AI be different than with previous technologies? Most importantly, what can governments, corporations, small businesses and individual workers do to not just avoid massive disruption, but rather position themselves to take outsized advantage of the opportunities?To find out, I recently hosted an excellent roundtable discussion at Clayton, Dubilier & Rice with NYU Professor Robert Seamans.Prof. Seamans’ studies how technology and governance structures affect strategic interactions between firms, affect incentives to innovate, and ultimately shape market outcomes. Previously he served under President Obama as a Senior Economist at the White House Council of Economic Advisers. He also co-authored an important review titled, simply, “AI and the Economy,” which explored the potential impact of AI on productivity and labor, and considered the various roles for regulation around antitrust, wages, data portability, and even immigration.  

Episode 072 (Life Stories Series) - Part 2 - Life Lessons From Mr. Ron Williams, former Chairman and CEO of Aetna, Inc. Mark Twain said, “THERE WAS NEVER YET AN UNINTERESTING LIFE. SUCH A THING IS AN IMPOSSIBILITY. INSIDE THE DULLEST EXTERIOR, THERE IS A DRAMA, A COMEDY, AND A TRAGEDY.” This is the Life Story Series. Join our Host, Christopher J Harris as he discusses Mr. Ron Williams, the author of the recently released book, Learning To Lead: The Journey to Leading Yourself, Leading Others, and Leading an Organization. This is Part 2 of the conversation around Mr. Williams' book and life wisdom. Catch Part 1 here. Mr. Williams is the chairman and CEO of RW2 Enterprises, LLC and former chairman and CEO of health insurance giant Aetna Inc. Mr. Williams is a Director of American Express, The Boeing Company and Johnson & Johnson. He serves as Operating Advisor to private equity firm Clayton, Dubilier & Rice, LLC and currently serves as Chairman of portfolio companies agilon health and naviHealth. He successfully guided two CD&R portfolio company exits: Envision Healthcare (NYSE:EVHC) and PharMEDium Corporation. Find out more about Mr. Williams and his work here. Have you ever stopped to consider what your life story is?  This question isn't about the specific details of what, when, how long. The question is about what's important, what did it mean, and other questions that unpack the WHY behind the what. Our goal over the next few episodes is to host guests that will share their unique stories and engage in a level of transparency of their past and present challenges that will allow us to not only learn from them, but appreciate their stories, what they are doing and then simultaneously appreciate our own stories and life narrative. This series has FOUR (4) Goals: We want you to think about your own life story Appreciate your own life story Listen to others' stories - their victories, challenges, and lessons learned Get a WISE IDEA about how other's stories could cause positive change in your own life. This series is sure to prompt smiles, evoke tears, and create "Ah Ha Moments". For Coaching, Questions, or Additional Information: You can contact us at info@thewiseideapodcast.com Subscribe via: iTunes, Google Play, Stitcher, TuneIn, RSS Feed, and Spotify Enjoy what you're hearing & seeing? Do you mind Rating & Reviewing This Podcast? Your ratings and reviews help us place the podcast in front of new leaders and listeners. Your feedback also lets me know how I can better serve you. If you have the desire to donate financially to The Wise Idea Podcast, you can do so here. A donation of any amount will be helpful in allowing us to creating the movement to INSPIRE WISDOM. DONATE HERE!                                                    About Our Host: Christopher J. Harris, a native of Palatka, Fla., is currently Executive Pastor of Crossover Church of Tampa, Fla. He is also the Director of Administration & Vision Implementation overseeing the day to day operations of the Atlanta Headquarters office for Full Gospel Baptist Church Fellowship International. He's served at ministries in Florida, South Carolina, North Carolina, and Chicago,IL. He's an author and blogger with two books, Temporary Assignments and Church Strategies and Ministry Systems. He's an alumnus of Florida State University, University of South Carolina, special studies at Princeton Theological Seminary and doctoral work at Nova Southeastern University. Harris currently resides in Florida with his wife Dr Carmen J Harris and their children. You can check him out here: www.ChristopherJHarris.com You can see his Social media here on Facebook, Instagram, Twitter, Periscope, and LinkedIn ALL at @CJHarrisOne Here are Christopher's Theological Beliefs: http://christopherjharris.com/what-i-believe/ He is affiliated with the following organizations (among others): www.CrossoverChurch.org , https://www.

Episode 071 (Life Stories Series) - Life Lessons From Mr. Ron Williams, former Chairman and CEO of Aetna, Inc. Mark Twain said, “THERE WAS NEVER YET AN UNINTERESTING LIFE. SUCH A THING IS AN IMPOSSIBILITY. INSIDE THE DULLEST EXTERIOR, THERE IS A DRAMA, A COMEDY, AND A TRAGEDY.” This is the Life Story Series. Join our Host, Christopher J Harris as he discusses Mr. Ron Williams, the author of the recently released book, Learning To Lead: The Journey to Leading Yourself, Leading Others, and Leading an Organization. Mr. Williams is the chairman and CEO of RW2 Enterprises, LLC and former chairman and CEO of health insurance giant Aetna Inc. Mr. Williams is a Director of American Express, The Boeing Company and Johnson & Johnson. He serves as Operating Advisor to private equity firm Clayton, Dubilier & Rice, LLC and currently serves as Chairman of portfolio companies agilon health and naviHealth. He successfully guided two CD&R portfolio company exits: Envision Healthcare (NYSE:EVHC) and PharMEDium Corporation. Find out more about Mr. Williams and his work here. In this episode, we take a brief journey into Mr. Williams' story through his book and pull on some of the wisdom shared in this book. Have you ever stopped to consider what your life story is?  This question isn't about the specific details of what, when, how long. The question is about what's important, what did it mean, and other questions that unpack the WHY behind the what. Our goal over the next few episodes is to host guests that will share their unique stories and engage in a level of transparency of their past and present challenges that will allow us to not only learn from them, but appreciate their stories, what they are doing and then simultaneously appreciate our own stories and life narrative. This series has FOUR (4) Goals: We want you to think about your own life story Appreciate your own life story Listen to others' stories - their victories, challenges, and lessons learned Get a WISE IDEA about how other's stories could cause positive change in your own life. This series is sure to prompt smiles, evoke tears, and create "Ah Ha Moments". For Coaching, Questions, or Additional Information: You can contact us at info@thewiseideapodcast.com Subscribe via: iTunes, Google Play, Stitcher, TuneIn, RSS Feed, and Spotify Enjoy what you're hearing & seeing? Do you mind Rating & Reviewing This Podcast? Your ratings and reviews help us place the podcast in front of new leaders and listeners. Your feedback also lets me know how I can better serve you. If you have the desire to donate financially to The Wise Idea Podcast, you can do so here. A donation of any amount will be helpful in allowing us to creating the movement to INSPIRE WISDOM. DONATE HERE!                                                    About Our Host: Christopher J. Harris, a native of Palatka, Fla., is currently Executive Pastor of Crossover Church of Tampa, Fla. He is also the Director of Administration & Vision Implementation overseeing the day to day operations of the Atlanta Headquarters office for Full Gospel Baptist Church Fellowship International. He's served at ministries in Florida, South Carolina, North Carolina, and Chicago,IL. He's an author and blogger with two books, Temporary Assignments and Church Strategies and Ministry Systems. He's an alumnus of Florida State University, University of South Carolina, special studies at Princeton Theological Seminary and doctoral work at Nova Southeastern University. Harris currently resides in Florida with his wife Dr Carmen J Harris and their children. You can check him out here: www.ChristopherJHarris.com You can see his Social media here on Facebook, Instagram, Twitter, Periscope, and LinkedIn ALL at @CJHarrisOne Here are Christopher's Theological Beliefs: http://christopherjharris.com/what-i-believe/ He is affiliated with the following organizations (among others): www.

Bill Conaty, former Senior Vice President of Human Resources at General Electric. Bill served alongside leaders like Jack Welch and Larry Bossidy and was responsible for developing the legendary HR practices that made GE one of the most admired companies in the world. Bill is recognized as a world leader in the area of human resources. He is the author of “The Talent Masters: Why Smart Leaders Put People Before Numbers”. He is a currently a senior advisory partner at Clayton, Dubilier and Rice. He serves as the Chair of the Board of Trustees at Bryant University and has served on the Advisory Board of Cornell University’s Center for Advanced Human Resource Studies. As a world leader in human resources, Bill is a highly sought-after speaker and featured guest on CNBC’s Squawk Box. Connect with David on Twitter: twitter.com/DavidNovakOGO See more Podcasts: davidnovakleadership.com/leadership-podcast/ Take our Free Recognition Survey: davidnovakleadership.com/survey

Private equity, of course, is a core part of most large institutional investors’ portfolios. How core? As of last year, some 90% of large U.S. public pension funds maintained allocations to private equity – an investment amount that totalled nearly 10% of all U.S. pension assets. In fact, for some global endowments, public pension systems and sovereign wealth funds around the world, the dollar-weighted average proportion of total AUM invested in private equity had increased from 6% to 12% in just the previous two years. But while private equity continues to grow as an asset class, many LPs seek new strategies, moving beyond the traditional fund investments, including co-investments, co-sponsorships, and even direct investments – bypassing the PE firms completely. Within this evolution of investment opportunities, a new approach has quietly been gaining traction. It’s called Solution Capital — highly customised transactions tailored for sellers who want to keep a substantial minority interest in the business being sold. How does Solution Capital work? Why would a seller consider this route? What’s its probability for success? Nate Sleeper is a Partner at Clayton, Dubilier & Rice. He has led or participated in dozens of these investments across a range of sectors.

In the first live episode ever, Steve and Trevor gather healthcare leaders for news roundup at the 2017 Leerink Healthcare IT conference in Chatham, Massachusetts. The team gets Ravi Sachdev, Partner at Clayton, Dubilier & Rice, Carl Byers, Executive Partner at F-Prime Capital, Robin Heffernan, Co-Founder & CEO of Circulation, and Tim Murphy, President & CEO of Beacon Health Options to review broad healthcare trends in reflection of the first half of 2017.

In episode 50 of MicrobeWorld Video, Vincent, Michael, and Stanley recorded episode #8 of the podcast This Week in Microbiology live at the 2011 ASM General Meeting in New Orleans, with guests Andreas Baümler, Nicole Dubilier, and Paul Rainey. They spoke about how pathogens benefit from disease, symbioses between chemosynthetic bacteria and marine invertebrates, and repetitive sequences in bacteria.

In episode 50 of MicrobeWorld Video, Vincent, Michael, and Stanley recorded episode #8 of the podcast This Week in Microbiology live at the 2011 ASM General Meeting in New Orleans, with guests Andreas Baümler, Nicole Dubilier, and Paul Rainey. They spoke about how pathogens benefit from disease, symbioses between chemosynthetic bacteria and marine invertebrates, and repetitive sequences in bacteria.

In episode 50 of MicrobeWorld Video, Vincent, Michael, and Stanley recorded episode #8 of the podcast This Week in Microbiology live at the 2011 ASM General Meeting in New Orleans, with guests Andreas Baümler, Nicole Dubilier, and Paul Rainey. They spoke about how pathogens benefit from disease, symbioses between chemosynthetic bacteria and marine invertebrates, and repetitive sequences in bacteria.

Vincent, Michael, and Stanley recorded TWiM #8 live at the 2011 ASM General Meeting in New Orleans, with guests Andreas Baümler, Nicole Dubilier, and Paul Rainey. They spoke about how pathogens benefit from disease, symbioses between chemosynthetic bacteria and marine invertebrates, and repetitive sequences in bacteria.